Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
paper
Cited
Public
Unavailable
- Authors
- Uhl, George R; Liu, Qing-Rong; Drgon, Tomas; Johnson, Catherine; Walther, Donna; Rose, Jed E; David, Sean P; Niaura, Ray; Lerman, Caryn
- Year
- 2008
- Journal
- Archives of general psychiatry
- PMID
- 18519826
- DOI
- 10.1001/archpsyc.65.6.683
- PMCID
- PMC2430596
CONTEXT: Smoking remains a major public health problem. Twin studies indicate that the ability to quit smoking is substantially heritable, with genetics that overlap modestly with the genetics of vulnerability to dependence on addictive substances. OBJECTIVES: To identify replicated genes that facilitate smokers' abilities to achieve and sustain abstinence from smoking (herein after referred to as quit-success genes) found in more than 2 genome-wide association (GWA) studies of successful vs unsuccessful abstainers, and, secondarily, to nominate genes for selective involvement in smoking cessation success with bupropion hydrochloride vs nicotine replacement therapy (NRT). DESIGN: The GWA results in subjects from 3 centers, with secondary analyses of NRT vs bupropion responders. SETTING: Outpatient smoking cessation trial participants from 3 centers. PARTICIPANTS: European American smokers who successfully vs unsuccessfully abstain from smoking with biochemical confirmation in a smoking cessation trial using NRT, bupropion, or placebo (N = 550). MAIN OUTCOME MEASURES: Quit-success genes, reproducibly identified by clustered nominally positive single-nucleotide polymorphisms (SNPs) in more than 2 independent samples with significant P values based on Monte Carlo simulation trials. The NRT-selective genes were nominated by clustered SNPs that display much larger t values for NRT vs placebo comparisons. The bupropion-selective genes were nominated by bupropion-selective results. RESULTS: Variants in quit-success genes are likely to alter cell adhesion, enzymatic, transcriptional, structural, and DNA, RNA, and/or protein-handling functions. Quit-success genes are identified by clustered nominally positive SNPs from more than 2 samples and are unlikely to represent chance observations (Monte Carlo P< .0003). These genes display modest overlap with genes identified in GWA studies of dependence on addictive substances and memory. CONCLUSIONS: These results support polygenic genetics for success in abstaining from smoking, overlap with genetics of substance dependence and memory, and nominate gene variants for selective influences on therapeutic responses to bupropion vs NRT. Molecular genetics should help match the types and/or intensity of antismoking treatments with the smokers most likely to benefit from them.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Germline lung cancer SNPs dysregulate known (LATS1) and novel (ADCY2) oncogenes through distal, spatially-constrained eQTLs. | Khoo A et al. | β | 2026 | β |
| DNA methylation heterogeneity correlates with field cancerization and prognosis in lung adenocarcinoma patients. | Zhou Y et al. | β | 2025 | β |
| Genome-wide association study reveals multiple loci for nociception and opioid consumption behaviors associated with heroin vulnerability in outbred rats. | Kuhn BN et al. | β | 2025 | β |
| Nicotine Metabolism-Related Genetic Polymorphisms Associated with Smoking Cessation in Korean Men: A Candidate Gene Association Study in a Korean Cohort. | Park JM et al. | β | 2025 | β |
| Pentilludin reduces rat amphetamine and remifentail self-administration with good pharmacologic and toxicologic profiles | Uhl G et al. | β | 2025 | β |
| Examining the Effect of Genes on Depression as Mediated by Smoking and Modified by Sex. | Voorhies K et al. | β | 2024 | β |
| Nicotine Motivated Behavior in <i>C. elegans</i>. | Salim C et al. | β | 2024 | β |
| A Case-Only Genome-Wide Interaction Study of Smoking and Bladder Cancer Risk: Results from the COBLAnCE Cohort. | Karimi M et al. | β | 2023 | β |
| Antidepressants for smoking cessation. | Hajizadeh A et al. | β | 2023 | β |
| A scoping review of smoking cessation pharmacogenetic studies to advance future research across racial, ethnic, and ancestral populations. | Prom-Wormley EC et al. | β | 2023 | β |
| Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D. | Uhl GR | β | 2023 | β |
| Structure-activity studies of PTPRD phosphatase inhibitors identify a 7-cyclopentymethoxy illudalic acid analog candidate for development. | Henderson IM et al. | β | 2022 | β |
| Transmembrane protein 108 inhibits the proliferation and myelination of oligodendrocyte lineage cells in the corpus callosum. | Wu Y et al. | β | 2022 | β |
| A systematic review of gene-by-intervention studies of alcohol and other substance use. | Neale ZE et al. | β | 2021 | β |
| Catenin Alpha 2 May Be a Biomarker or Potential Drug Target in Psychiatric Disorders with Perseverative Negative Thinking. | Eszlari N et al. | β | 2021 | β |
| LAR Receptor Tyrosine Phosphatase Family in Healthy and Diseased Brain. | Cornejo F et al. | β | 2021 | β |
| Systems genetic analysis of nicotine withdrawal deficits in hippocampus-dependent learning. | Goldberg LR et al. | β | 2021 | β |
| Timing of chronic obstructive pulmonary disease diagnosis in lung cancer prognosis: a clinical and genomic-based study. | Dai J et al. | β | 2021 | β |
| Antidepressants for smoking cessation. | Howes S et al. | β | 2020 | β |
| Mixed-model admixture mapping identifies smoking-dependent loci of lung function in African Americans. | Ziyatdinov A et al. | β | 2020 | β |
| Systems Biology Analysis Reveals Eight SLC22 Transporter Subgroups, Including OATs, OCTs, and OCTNs. | Engelhart DC et al. | β | 2020 | β |
| Chronic Obstructive Pulmonary Disease Risk and Smoking Cessation Changes Induced by <i>CHRNA5-A3</i> and <i>CHRNB3-A6</i> Variation in a Chinese Male Population. | Zhao L et al. | β | 2019 | β |
| Differentially methylated regions in bipolar disorder and suicide. | Gaine ME et al. | β | 2019 | β |
| Epigenome-wide association of father's smoking with offspring DNA methylation: a hypothesis-generating study. | MΓΈrkve Knudsen GT et al. | β | 2019 | β |
| Epigenome-wide association study of serum cotinine in current smokers reveals novel genetically driven loci. | Gupta R et al. | β | 2019 | β |
| Neurogenetic determinants and mechanisms of addiction to nicotine and smoked tobacco. | Sharp BM et al. | β | 2019 | β |
| PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes. | Uhl GR et al. | β | 2019 | β |
| Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist. | Uhl GR et al. | β | 2018 | β |
| Pathways to precision medicine in smoking cessation treatments. | Chen LS et al. | β | 2018 | β |
| Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. | Liu Y et al. | β | 2018 | β |
| The Role of Cell Adhesion Molecule Genes Regulating Neuroplasticity in Addiction. | Muskiewicz DE et al. | β | 2018 | β |
| Use of polygenic risk scores of nicotine metabolism in predicting smoking behaviors. | Chen LS et al. | β | 2018 | β |
| Alcohol and nicotine codependence-associated DNA methylation changes in promoter regions of addiction-related genes. | Xu H et al. | β | 2017 | β |
| Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions. | Akbar MA et al. | β | 2017 | β |
| Cdh13 and AdipoQ gene knockout alter instrumental and Pavlovian drug conditioning. | King CP et al. | β | 2017 | β |
| CHN2 Promoter Methylation Change May Be Associated With Methamphetamine Dependence. | Hao L et al. | β | 2017 | β |
| Genome-wide meta-analysis identifies a novel susceptibility signal at CACNA2D3 for nicotine dependence. | Yin X et al. | β | 2017 | β |
| GRONS: a comprehensive genetic resource of nicotine and smoking. | Fang Z et al. | β | 2017 | β |
| iTRAQ proteomic analysis of the hippocampus in a rat model of nicotine-induced conditioned place preference. | Zhu B et al. | β | 2017 | β |
| Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. | Schuit E et al. | β | 2017 | β |
| Role of LRRTMs in synapse development and plasticity. | Roppongi RT et al. | β | 2017 | β |
| The genetic epidemiology of substance use disorder: A review. | Prom-Wormley EC et al. | β | 2017 | β |
| Alcohol-related genes show an enrichment of associations with a persistent externalizing factor. | Ashenhurst JR et al. | β | 2016 | β |
| Associations between smoking behavior-related alleles and the risk of melanoma. | Wu W et al. | β | 2016 | β |
| Cadherin 13: human <i>cis</i>-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice. | Drgonova J et al. | β | 2016 | β |
| Genetic imaging consortium for addiction medicine: From neuroimaging to genes. | Mackey S et al. | β | 2016 | β |
| Genetic Risk Determinants for Cigarette Smoking Dependence in Mexican Mestizo Families. | Svyryd Y et al. | β | 2016 | β |
| Smokescreen: a targeted genotyping array for addiction research. | Baurley JW et al. | β | 2016 | β |
| Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models. | Drgonova J et al. | β | 2015 | β |
| Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies. | Nishizawa D et al. | β | 2015 | β |
| Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date. | Mamoun M et al. | β | 2015 | β |
| CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. | Chen LS et al. | β | 2015 | β |
| CYP2A6 Polymorphisms May Strengthen Individualized Treatment for Nicotine Dependence. | Akrodou YM | β | 2015 | β |
| Gene-gene interaction of ΞΌ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect. | Misailidis G et al. | β | 2015 | β |
| Human cell adhesion molecules: annotated functional subtypes and overrepresentation of addiction-associated genes. | Zhong X et al. | β | 2015 | β |
| KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction. | Padula AE et al. | β | 2015 | β |
| Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. | Tyndale RF et al. | β | 2015 | β |
| Mouse Model for Protein Tyrosine Phosphatase D (<i>PTPRD</i>) Associations with Restless Leg Syndrome or Willis-Ekbom Disease and Addiction: Reduced Expression Alters Locomotion, Sleep Behaviors and Cocaine-Conditioned Place Preference. | Drgonova J et al. | β | 2015 | β |
| Pathways and networks-based analysis of candidate genes associated with nicotine addiction. | Liu M et al. | β | 2015 | β |
| Prioritizing Genes Related to Nicotine Addiction Via a Multi-source-Based Approach. | Liu X et al. | β | 2015 | β |
| Addiction science: Uncovering neurobiological complexity. | Volkow ND et al. | β | 2014 | β |
| A non-parametric approach for detecting gene-gene interactions associated with age-at-onset outcomes. | Li M et al. | β | 2014 | β |
| Antidepressants for smoking cessation. | Hughes JR et al. | β | 2014 | β |
| Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. | Tang H et al. | β | 2014 | β |
| CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction. | Chen LS et al. | β | 2014 | β |
| Curious cases: Altered dose-response relationships in addiction genetics. | Uhl GR et al. | β | 2014 | β |
| Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample. | Loukola A et al. | β | 2014 | β |
| Identification of DNA methylation changes in newborns related to maternal smoking during pregnancy. | Markunas CA et al. | β | 2014 | β |
| Identifying Genetic Variants for Addiction via Propensity Score Adjusted Generalized Kendall's Tau. | Jiang Y et al. | β | 2014 | β |
| Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction. | Chen LS et al. | β | 2014 | β |
| Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. | Leventhal AM et al. | β | 2014 | β |
| Organic cation transporter variation and response to smoking cessation therapies. | Bergen AW et al. | β | 2014 | β |
| Performing integrative functional genomics analysis in GeneWeaver.org. | Jay JJ et al. | β | 2014 | β |
| Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). | Chen LS et al. | β | 2014 | β |
| Placental genome and maternal-placental genetic interactions: a genome-wide and candidate gene association study of placental abruption. | Denis M et al. | β | 2014 | β |
| Protection genes in nucleus accumbens shell affect vulnerability to nicotine self-administration across isogenic strains of adolescent rat. | Chen H et al. | β | 2014 | β |
| Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances. | Uhl GR et al. | β | 2014 | β |
| Adapting smoking cessation treatment according to initial response to precessation nicotine patch. | Rose JE et al. | β | 2013 | β |
| Association of a novel polymorphism of the Ξ²2-chimaerin gene (CHN2) with smoking. | Barrio-Real L et al. | β | 2013 | β |
| Biomarkers for smoking cessation. | Bough KJ et al. | β | 2013 | β |
| Environmental and genomic factors as well as interventions influencing smoking cessation: a systematic review of reviews and a proposed working model. | de Viron S et al. | β | 2013 | β |
| Genome-wide association study of liver enzymes in korean children. | Park TJ et al. | β | 2013 | β |
| Genomics and personalized medicine: <i>CHRNA5-CHRNA3-CHRNB4</i> and smoking cessation treatment. | Chen LS et al. | β | 2013 | β |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | β | 2013 | β |
| Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. | David SP et al. | β | 2013 | β |
| Investigation of novel genes for lung function in children and their interaction with tobacco smoke exposure: a preliminary report. | Panasevich S et al. | β | 2013 | β |
| NCK2 is significantly associated with opiates addiction in African-origin men. | Liu Z et al. | β | 2013 | β |
| Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. | Bergen AW et al. | β | 2013 | β |
| NKAIN1-SERINC2 is a functional, replicable and genome-wide significant risk gene region specific for alcohol dependence in subjects of European descent. | Zuo L et al. | β | 2013 | β |
| Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. | McClure JB et al. | β | 2013 | β |
| Pharmacogenetics of chronic obstructive pulmonary disease. | Hizawa N | β | 2013 | β |
| A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation. | Verhagen M et al. | β | 2012 | β |
| CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland. | Hardin M et al. | β | 2012 | β |
| Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. | Leventhal AM et al. | β | 2012 | β |
| Effects of smoking and obesity on the association between CDH13 (rs3865188) and adiponectin among Korean men: the KARE study. | Jo J et al. | β | 2012 | β |
| Emerging genetics of COPD. | Berndt A et al. | β | 2012 | β |
| Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D. | Adkins DE et al. | β | 2012 | β |
| Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence. | Zuo L et al. | β | 2012 | β |
| Glutamate and synaptic plasticity systems and smoking behavior: results from a genetic association study. | dos Santos VA et al. | β | 2012 | β |
| Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. | Chen LS et al. | β | 2012 | β |
| Large scale association analysis for drug addiction: results from SNP to gene. | Guo X et al. | β | 2012 | β |
| Large-scale genome-wide association study of Asian population reveals genetic factors in FRMD4A and other loci influencing smoking initiation and nicotine dependence. | Yoon D et al. | β | 2012 | β |
| Mouse models for studying genetic influences on factors determining smoking cessation success in humans. | Hall FS et al. | β | 2012 | β |
| Neuroadaptation in nicotine addiction: update on the sensitization-homeostasis model. | DiFranza JR et al. | β | 2012 | β |
| Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D. | Clark SL et al. | β | 2012 | β |
| The CHRNA5-A3-B4 gene cluster in nicotine addiction. | Berrettini WH et al. | β | 2012 | β |
| Addiction as a systems failure: focus on adolescence and smoking. | Baler RD et al. | β | 2011 | β |
| A quantitative-trait genome-wide association study of alcoholism risk in the community: findings and implications. | Heath AC et al. | β | 2011 | β |
| Association of a variant in the CHRNA5-A3-B4 gene cluster region to heavy smoking in the Italian population. | Sorice R et al. | β | 2011 | β |
| Black and White adults' perspectives on the genetics of nicotine addiction susceptibility. | Park ER et al. | β | 2011 | β |
| Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder. | Lydall GJ et al. | β | 2011 | β |
| Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics. | Perkins KA et al. | β | 2011 | β |
| Ethical concerns related to developing pharmacogenomic treatment strategies for addiction. | Shields AE | β | 2011 | β |
| Family-based association analysis of alcohol dependence in the COGA sample and replication in the Australian twin-family study. | Wang KS et al. | β | 2011 | β |
| Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes. | Mozhui K et al. | β | 2011 | β |
| Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. | Murea M et al. | β | 2011 | β |
| Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. | Johnson C et al. | β | 2011 | β |
| Individualized smoking cessation treatment: roles for sets of genomic markers. | Uhl GR et al. | β | 2011 | β |
| Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction. | Li CY et al. | β | 2011 | β |
| Personalized medicine and tobacco-related health disparities: is there a role for genetics? | Carlsten C et al. | β | 2011 | β |
| Pharmacogenetics of alcohol, nicotine and drug addiction treatments. | Sturgess JE et al. | β | 2011 | β |
| Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials. | David SP et al. | β | 2011 | β |
| Proactive recruitment of cancer patients' social networks into a smoking cessation trial. | Bastian LA et al. | β | 2011 | β |
| Relapse prevention for addictive behaviors. | Hendershot CS et al. | β | 2011 | β |
| 'Smoking genes': a genetic association study. | Verde Z et al. | β | 2011 | β |
| SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development. | Hersh CP et al. | β | 2011 | β |
| The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. | Castaldi PJ et al. | β | 2011 | β |
| The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatment. | Lori A et al. | β | 2011 | β |
| Variant within the promoter region of the CHRNA3 gene associated with FTN dependence is not related to self-reported willingness to quit smoking. | Marques-Vidal P et al. | β | 2011 | β |
| A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. | Hong LE et al. | β | 2010 | β |
| A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations. | Lind PA et al. | β | 2010 | β |
| A human-specific de novo protein-coding gene associated with human brain functions. | Li CY et al. | β | 2010 | β |
| Are adolescents with ADHD interested in genetic testing for nicotine addiction susceptibility? | Herbert LJ et al. | β | 2010 | β |
| Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans. | Li MD et al. | β | 2010 | β |
| Association of NPAS3 exonic variation with schizophrenia. | Macintyre G et al. | β | 2010 | β |
| Associations of ECP (eosinophil cationic protein)-gene polymorphisms to allergy, asthma, smoke habits and lung function in two Estonian and Swedish sub cohorts of the ECRHS II study. | JΓΆnsson UB et al. | β | 2010 | β |
| Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population. | Li MD et al. | β | 2010 | β |
| Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. | Wang J et al. | β | 2010 | β |
| Confirmation of top polymorphisms in hypertension genome wide association study among Han Chinese. | Niu W et al. | β | 2010 | β |
| Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. | De Ruyck K et al. | β | 2010 | β |
| Genome wide association for addiction: replicated results and comparisons of two analytic approaches. | Drgon T et al. | β | 2010 | β |
| Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement. | Uhl GR et al. | β | 2010 | β |
| Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. | Uhl GR et al. | β | 2010 | β |
| Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. | Edwards TL et al. | β | 2010 | β |
| Genome-wide association study identifies five loci associated with lung function. | Repapi E et al. | β | 2010 | β |
| Hippocampal and striatal gray matter volume are associated with a smoking cessation treatment outcome: results of an exploratory voxel-based morphometric analysis. | Froeliger B et al. | β | 2010 | β |
| Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. | Rose JE et al. | β | 2010 | β |
| Pharmacogenetics of alcohol and alcohol dependence treatment. | Kranzler HR et al. | β | 2010 | β |
| Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities. | Hersh CP | β | 2010 | β |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | β | 2010 | β |
| Pharmacogenetics of smoking cessation therapy. | Kortmann GL et al. | β | 2010 | β |
| Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. | Thorgeirsson TE et al. | β | 2010 | β |
| Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans. | David SP et al. | β | 2010 | β |
| Significant association of glutamate receptor, ionotropic N-methyl-D-aspartate 3A (GRIN3A), with nicotine dependence in European- and African-American smokers. | Ma JZ et al. | β | 2010 | β |
| The impact of smoking in Crohn's disease: no smoke without fire. | Aldhous MC et al. | β | 2010 | β |
| The public health utility of genome-wide association study results for smoking behavior. | Furberg H et al. | β | 2010 | β |
| The Role of Genetics in Nicotine Dependence: Mapping the Pathways from Genome to Syndrome. | Mackillop J et al. | β | 2010 | β |
| Topiramate in the treatment of substance-related disorders: a critical review of the literature. | Shinn AK et al. | β | 2010 | β |
| A genome-wide association study suggests that a locus within the ataxin 2 binding protein 1 gene is associated with hand osteoarthritis: the Treat-OA consortium. | Zhai G et al. | β | 2009 | β |
| Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence. | Kranzler HR et al. | β | 2009 | β |
| Cognitive flexibility is associated with KIBRA variant and modulated by recent tobacco use. | Zhang H et al. | β | 2009 | β |
| Constitutional mechanisms of vulnerability and resilience to nicotine dependence. | Hiroi N et al. | β | 2009 | β |
| Convergent genome wide association results for bipolar disorder and substance dependence. | Johnson C et al. | β | 2009 | β |
| Data-driven methods to discover molecular determinants of serious adverse drug events. | Chiang AP et al. | β | 2009 | β |
| Dopamine genes and nicotine dependence in treatment-seeking and community smokers. | Bergen AW et al. | β | 2009 | β |
| Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. | Drgon T et al. | β | 2009 | β |
| Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes. | Drgon T et al. | β | 2009 | β |
| Genome-wide association studies: powerful tools for improving drug safety and efficacy. | Gurwitz D et al. | β | 2009 | β |
| Genome-wide association study of alcohol dependence. | Treutlein J et al. | β | 2009 | β |
| Genome-wide association study of smoking initiation and current smoking. | Vink JM et al. | β | 2009 | β |
| Linkage analysis of adult height in a large pedigree from a Dutch genetically isolated population. | Axenovich TI et al. | β | 2009 | β |
| Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials. | Uhl GR et al. | β | 2009 | β |
| Nicotine dependence: biology, behavior, and treatment. | Ray R et al. | β | 2009 | β |
| OKCAM: an ontology-based, human-centered knowledgebase for cell adhesion molecules. | Li CY et al. | β | 2009 | β |
| Preventing postpartum smoking relapse: an opportunity for neonatal nurses. | Forest S | β | 2009 | β |
| Promise of pharmacogenomics in smoking cessation. | Uhl GR | β | 2009 | β |
| Selected summaries from the XVI World Congress of Psychiatric Genetics, Osaka, Japan, 11-15 October 2008. | Bergen S et al. | β | 2009 | β |
| Smoking and smoking cessation in disadvantaged women: assessing genetic contributions. | Uhl GR et al. | β | 2009 | β |
| Supplementing high-density SNP microarrays for additional coverage of disease-related genes: addiction as a paradigm. | Saccone SF et al. | β | 2009 | β |
| Tobacco addiction and pharmacogenetics of nicotine metabolism. | Swan GE et al. | β | 2009 | β |
| Transdisciplinary Tobacco Use Research Centers: research achievements and future implications. | Baker TB et al. | β | 2009 | β |
| Addiction Reviews. Preface. | Uhl GR | β | 2008 | β |
| Disrupting nicotine reinforcement: from cigarette to brain. | Rose JE | β | 2008 | β |
| Genetic variation in the dopamine pathway and smoking cessation. | David SP et al. | β | 2008 | β |
| Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples. | Johnson C et al. | β | 2008 | β |
| Genomics of smoking exposure and cessation: lessons for cancer prevention and treatment. | Penning TM et al. | β | 2008 | β |
| Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. | Uhl GR et al. | β | 2008 | β |
| Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. | Lesch KP et al. | β | 2008 | β |
| Neuroimaging, genetics and the treatment of nicotine addiction. | Ray R et al. | β | 2008 | β |
| Antidepressants for smoking cessation. | Hughes JR et al. | β | 2007 | β |